Heroin-assisted treatment as a response to the public health problem of opiate dependence

被引:64
作者
Fischer, B
Rehm, J
Kirst, M
Casas, M
Hall, W
Krausz, M
Metrebian, N
Reggers, J
Uchtenhagen, A
Van Den Brink, W
Van Ree, JM
机构
[1] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5S 1A8, Canada
[2] Ctr Addict & Mental Hlth, Toronto, ON, Canada
[3] Res Inst Addict, Zurich, Switzerland
[4] Hosp Univ Vall Hebron, Serv Psiquiatria, Barcelona, Spain
[5] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia
[6] Klin Psychiat & Psychotherapie, Hamburg, Germany
[7] Imperial Coll Sch Med, Dept Social Sci & Med, London, England
[8] CHU Sart Tilman, Dept Psychiat, B-4000 Liege, Belgium
[9] Cent comm Treatment Heroin Addicts, Utrecht, Netherlands
关键词
clinical trials; heroin-assisted treatment; opiate dependence; opiate pharmacotherapy treatment; public health;
D O I
10.1093/eurpub/12.3.228
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Injection drug use (involving the injection of illicit opiates) poses serious public health problems in many countries. Research has indicated that injection drug users are at higher risk for morbidity in the form of HIV/AIDS and Hepatitis B and C, and drug-related mortality, as well as increased criminal activity. Methadone maintenance treatment is the most prominent form of pharmacotherapy treatment for illicit opiate dependence in several countries, and its application varies internationally with respect to treatment regulations and delivery modes. In order to effectively treat those patients who have previously been resistant to methadone maintenance treatment, several countries have been studying and/or considering heroin-assisted treatment as a complementary form of opiate pharmacotherapy treatment. This paper provides an overview of the prevalence of injection drug use and the opiate dependence problem internationally, the current opiate dependence treatment landscape in several countries, and the status of ongoing or planned heroin-assisted treatment trials in Australia, Canada and certain European countries.
引用
收藏
页码:228 / 234
页数:7
相关论文
共 68 条
[11]   METHADONE DOSAGE AND RETENTION OF PATIENTS IN MAINTENANCE TREATMENT [J].
CAPLEHORN, JRM ;
BELL, J .
MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (03) :195-199
[12]  
CASAS M, 2001, INT NETW C HER ASS T
[13]   Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs on-site vaccination at a syringe exchange program [J].
Des Jarlais, DC ;
Fisher, DG ;
Newman, JC ;
Trubatch, BN ;
Yancovitz, M ;
Paone, D ;
Perlman, D .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2001, 91 (11) :1791-1792
[14]  
DOBLERMIKOLA A, 1998, METHADON HEROIN UNTE
[15]  
Effective medical treatment of opiate addiction, 1998, JAMA, V280, P1936, DOI DOI 10.1001/JAMA.280.22.1936
[16]  
*EUR MON CTR DRUGS, 1999, ANN REP STAT DRUGS P
[17]  
European Monitorning Centre for Drugs and Drug Addiction, 2000, ANN REP STAT DRUGS P
[18]  
FARRELL M, 2001, REV CURRENT PRACTICE
[19]  
Fischer B, 2000, CAN MED ASSOC J, V162, P1709
[20]   Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada [J].
Fischer, B .
JOURNAL OF PUBLIC HEALTH POLICY, 2000, 21 (02) :187-210